Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02055326 · ClinicalTrials.gov registry record · NA
Yoga for Men Attempting Smoking Cessation
A NA study, sponsored by The Miriam Hospital.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
NCT02055326: Completed NA study, sponsored by The Miriam Hospital.
NCT02055326 is a NA study that has completed, run by The Miriam Hospital. The registered enrollment target is 38 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02055326, a NA study, has completed, sponsored by The Miriam Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
Study Summary
The purpose of this pilot study is to examine the feasibility and preliminary efficacy of a quit-smoking program that combines behavioral therapy with either yoga, or a health \& wellness program that serves as a contact control.
Primary Outcome
7-day point prevalence abstinence was measured at 8 weeks, 3 and 6 months follow up
Interventions
- BEHAVIORAL Yoga
- BEHAVIORAL Health & Wellness
- BEHAVIORAL Cognitive Behavioral Therapy for Smoking Cessation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2009-09 |
| Est. Completion | 2011-07 |
| Phase | NA |
What the finished NCT02055326 record still lists
NCT02055326 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 3 interventions - of which Yoga is the first listed.
NCT02055326 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02055326 about?
NCT02055326 is a clinical study titled "Yoga for Men Attempting Smoking Cessation". The purpose of this pilot study is to examine the feasibility and preliminary efficacy of a quit-smoking program that combines behavioral therapy with either yoga, or a health \& wellness program that serves as a contact control.
What is the current status of trial NCT02055326?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2009-09. Estimated completion is 2011-07.
What interventions are being tested in trial NCT02055326?
The interventions under investigation include: Yoga (BEHAVIORAL), Health & Wellness (BEHAVIORAL), Cognitive Behavioral Therapy for Smoking Cessation (BEHAVIORAL).
Who is sponsoring clinical trial NCT02055326?
This trial is sponsored by The Miriam Hospital, which has 136 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02055326's enrollment target sits among peer trials
38 1538th of 2000 higher than 461 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia